EX-99.4 30 tm2132809d11_ex99-4.htm EXHIBIT 99.4

Exhibit 99.4

April 5, 2022

 

BELITE BIO, INC

5820 Oberlin Drive, Suite 101

San Diego, CA 92121

 

Ladies and Gentlemen:

 

Pursuant to Rule 438 under the Securities Act of 1933, as amended, I hereby consent to the reference of my name as a director of BELITE BIO, INC (the “Company”), effective immediately upon the effectiveness of the Company’s registration statement on Form F-1 filed by the Company with the U.S. Securities and Exchange Commission.

 

Sincerely yours,
  
/s/Ita Lu 
Name: Ita Lu